Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria

European Journal of Clinical Pharmacology

Volumn 66, Issue 7, 2010, Pages 705-712

  Ashley, Elizabeth A ^a   Stepniewska, Kasia ^b,c   Lindegardh, Niklas ^b,c   Annerberg, Anna ^b   Tarning, Joel ^b,c   McGready, Rose ^a,b,c   Phaiphun, Lucy ^a   Singhasivanon, Pratap ^b   White, Nicholas J ^b,c   Nosten, François ^a,b,c  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Artemisinin combination therapy; Capillary blood; Malaria; Piperaquine

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; PIPERAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; DRUG COMBINATION; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PHLEBOTOMY; PLASMA; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION; VENOUS BLOOD; BLOOD; BLOOD ANALYSIS; CAPILLARY; CHEMISTRY; DRUG COMBINATION; FINGER; MALARIA, FALCIPARUM; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); VASCULARIZATION;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; BLOOD CHEMICAL ANALYSIS; CAPILLARIES; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; FEMALE; FINGERS; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PHLEBOTOMY; PLASMA; QUINOLINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77955569619     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0804-7     Document Type: Article

References (34)

1. Ashley EA, Krudsood S, Phaiphun L, Srivilairit S, McGready R, Leowattana W, Hutagalung R, Wilairatana P, Brockman A, Looareesuwan S, Nosten F, White NJ (2004) Randomized, controlled dose-optimization studies of dihydroartemisininpiperaquine for the treatment of uncomplicated multidrugresistant falciparum malaria in Thailand. J Infect Dis 190 (10):1773-1782, Erratum in: J Infect Dis. 2005;191(7):1204
2. Ashley EA, McGready R, Hutagalung R, Phaiphun L, Slight T, Proux S, Thwai KL, Barends M, Looareesuwan S, White NJ, Nosten F (2005) A randomized, controlled study of a simple,once-daily regimen of dihydroartemisinin- piperaquine for thetreatment of uncomplicated, multidrug-resistant falciparum malaria. Clin Infect Dis 41(4):425-432
3. Bergqvist Y, Domeij-Nyberg B (1983) Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr 272 (1):137-148
4. Casper R, Garver DL, Dekirmenjian H, Chang S, Davis J (1980) Phenothiazine levels in plasma and red blood cells. Arch Gen Psychiatry 37:301-305
5. Daae LN, Halvorsen S, Mathisen PM, Mironska K (1988) A comparison between haematological parameters in 'capillary' and venous blood from healthy adults. Scand J Clin Lab Invest 48(7):723-726, Erratum in: Scand J Clin Lab Invest 1989;49 (3):305
6. Daae LN, Hallerud M, Halvorsen S (1991) A comparison between haematological parameters in 'capillary' and venous blood samplesfrom hospitalized children aged 3 months to 14 years. Scand J Clin Lab Invest 51(7):651-654
7. Feusner JH, Behrens JA, Detter JC, Cullen TC (1979) Platelet counts in capillary blood. Am J Clin Pathol 72(3):410-414
8. Garver DL, Dekirmenjian H, Davis JM, Casper R, Ericksen S(1977) Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cells - bound butaperazine. Am J Psychiatry 134:304-307
9. Gustafasson LL, Walker O, Alván G, Beermann B, Estevez F, Gleisner L, Lindström B, Sjöqvist F (1983) Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 15(4):471-479
10. Hai TN, Hietala SF, Van Huong N, Ashton M (2008) The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers. Acta Trop 107(2):145-149
11. Hien TT, Davis TM, Chuong LV, Ilett KF, Sinh DX, Phu NH, Agus C, Chiswell GM, White NJ, Farrar J (2004) Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrob Agents Chemother 48(11):4234-4239, Erratum in: Antimicrob Agents Chemother. 2005;49(2):871
12. Hinderling PH (1997) Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics. Pharmacol Rev 49 (3):279-295
13. Hung TY, Davis TM, Ilett KF (2003) Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci 791 (1-2):93-101
14. Hung TY, Davis TM, Ilett KF, Karunajeewa H, Hewitt S, DenisMB, Lim C, Socheat D (2004) Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparumor vivax malaria. Br J Clin Pharmacol 57(3):253-262
15. Lindegardh N, Ashton M, Bergqvist Y (2003) Automated solidphase extraction method for the determination of piperaquine inwhole blood by rapid liquid chromatography. Ther Drug Monit 25 (5):544-551 (Pubitemid 37238887)
16. Lindegardh N, Ashton M, Bergqvist Y (2003) Automated solidphase extraction method for the determination of piperaquine in plasma by peak compression liquid chromatography. J Chromatogr Sci 41(1):44-49
17. Lindegardh N, White NJ, Day NP (2005) High throughput assay for the determination of piperaquine in plasma. J Pharm Biomed Anal 39(3-4):601-605 (Pubitemid 41196069)
18. Mayxay M, Thongpraseuth V, Khanthavong M, Lindeardh N, Barends M, Keola S, Pongvongsa T, Phompida S, Phetsouvanh R, Stepniewska K,White NJ, Newton PN (2006) An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisininpiperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos). Trop Med Int Health 11(8):1157-1165
19. Orjih AU (1987) Increased accumulation of chloroquine and desethylchloroquine in homozygous sickle cells. Bull WHO 65 (1):51-55
20. Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, ter Kuile F, Chongsuphajaisiddhi T, White NJ (2001) Factors contributing to anemia after uncomplicated falciparum malaria.Am J Trop Med Hyg 65(5):614-622
21. Rombo L, Ericsson O, Alvan G, Lindstrom B, Gustafsson LL, Sjoqvist F (1985) Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. Ther Drug Monit 7(2):211-215
22. Roshammar D, Hai TN, Friberg Hietala S, Van Huong N, Ashton M (2006) Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects. Eur J Clin Pharmacol 62(5):335-341
23. Sim IK, Davis TM, Ilett KF (2005) Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob Agents Chemother 49(6):2407-2411
24. Simpson JA, Aarons L, White NJ (2001) How can we do pharmacokinetic studies in the tropics? Trans R Soc Trop MedHyg 95:347-351
25. Smithuis F, Kyaw MK, Phe O, Aye KZ, Htet L, Barends M, Lindegardh N, Singtoroj T, Ashley E, Lwin S, Stepniewska K,White NJ (2006) Efficacy and effectiveness of dihydroartemisininpiperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomized comparison. Lancet 367(9528):2075-2085
26. Svensson C, Nyberg G, Axelsson R, Mårtensson E (1986) Concentrations of thioridazine and thioridazine metabolites in erythrocytes. Psychopharmacology 89:291-293
27. Tai DY, Chan KW, Chee YC, Mak KH (1995) Comparison of platelet counts in simultaneous venous and capillary blood samples using an automated platelet analyser. Singapore Med J 36(3):263-266
28. Tarning J, Bergqvist Y, Day NP, Bergquist J, Arvidsson B, White NJ, Ashton M, Lindegardh N (2006) Characterization of human urinary metabolites of the antimalarial piperaquine. Drug Metab Dispos 34(12):2011-2019
29. Tarning J, Lindegardh N, Annerberg A, Singtoroj T, Day NP, Ashton M, White NJ (2005) Pitfalls in estimating piperaquin elimination. Antimicrob Agents Chemother49(12):5127-5128
30. Tarning J, Ashley EA, Lindegardh N, Stepniewska K, Phaiphun L, Day NP, McGready R, Ashton M, Nosten F, White NJ (2008) Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin- piperaquine in patients with acute uncomplicated Plasmodium falciparum malaria in Thailand. Antimicrob Agents Chemother 52(3):1052-1061, 2007
31. Teja-Isavadharm P, Watt G, Eamsila C, Jongsakul K, Li Q, Keeratithakul G, Sirisopana N, Luesutthiviboon L, Brewer TG (2001) Kyle DE.Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria. Am J Trop Med Hyg 65(6):717-721
32. White NJ (1994) Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans R Soc Trop Med Hyg 88 [Suppl 1]:S41-S43
33. White NJ, Stepniewska K, Barnes K, Price RN, Simpson J (2008) Simplified antimalarial therapeutic monitoring: using the day-7 drug level? Trends Parasitol 24:159-163
34. YangZW, Yang SH, Chen L, Qu J, Zhu J, Tang Z (2001) Comparison of blood counts in venous, fingertip and arterial blood and their measurement variation. Clin Lab Haematol 23(3):155-159